Skip to the page

Data / Form D filings / Bench7 Inc.

Bench7 Inc.: Form D filing

Bench7 Inc., a biotechnology company in Bismarck, ND, filed a Form D with the SEC in 2025. The latest, on March 20, 2025, reports $100,000 sold of a $100,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
929 PARKVIEW DRIVE, Bismarck, ND, 58501
Phone
(701) 426-4614
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2062359

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 20, 2025New notice$100,000$100,0002Mar 11, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jesse James WeiandExecutive Officer, Director
Chris James PearceExecutive Officer, Director
John James PerssonExecutive Officer, Director

Every Form D from the week of Mar 17, 2025 · All recent filings in North Dakota · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Bench7 Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.